Eikon Therapeutics is planning to become the second biotech to go public in 2026 in another sign the public markets are looking increasingly attractive to drug developers. Eikon emerged publicly in ...

Eikon Therapeutics, Inc. (EIKN) has filed to raise development capital in an IPO of its common stock, according to SEC S-1 registration information. The company is a large biopharma firm developing ...

Former MSD head of R&D Roger Perlmutter has continued the swift development track for cancer start-up Eikon Therapeutics, filing an IPO to build its already healthy cash position further. Eikon has ...

Quant funds have had a tough start to the year. The average quant started the year down 1%, according to Goldman Sachs. Managers such as Renaissance Technologies and Schonfeld have lost money in ...

Alexandre Corhay, an assistant professor of finance at the Rotman School of Management, has been named one of the 50 best undergraduate business professors of 2025 by Poets&Quants for Undergraduates.

With countless applications and a combination of approachability and power, Python is one of the most popular programming languages for beginners and experts alike. We’ve compiled a list of 10 online ...

George Patterson, the managing director and the chief investment officer for $111 billion PGIM Quantitative Solutions, has been using artificial intelligence in his quant investing strategies for ...

DeepSeek founder Liang Wenfeng’s quantitative hedge fund generated returns of more than 50% last year, boosting the potential war chest for a company that has already shaken up the global tech ...

Jean Herrell’s crypto journey began in 2014 while studying computer science in Taiwan. He said the experience of seeing how governments could restrict financial freedom led him to Bitcoin (BTC), and ...

Survey of more than 150 quants, research analysts, and data scientists examines how AI is being used in investment research workflows Building on last year's Research Data survey, which highlighted ...